Regeneron Pharmaceuticals Inc. buy TD Cowen
Start price
23.04.26
/
50%
€655.50
Target price
23.04.27
€820.61
Performance (%)
1.29%
Price
10:18
€663.00
Summary
This prediction is currently active. With a performance of 1.29%, the BUY prediction by TD_Cowen for Regeneron Pharmaceuticals Inc. is trending in the right direction. A total of €0.94 was paid as dividends for this prediction. This prediction currently runs until 23.04.27. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regeneron Pharmaceuticals Inc. | 8.058% | 8.058% |
| iShares Core DAX® | 3,26 % | 2,07 % |
| iShares Nasdaq 100 | 5,70 % | -0,60 % |
| iShares Nikkei 225® | 7,77 % | -4,75 % |
| iShares S&P 500 | 2,80 % | 2,25 % |
Comments by TD_Cowen for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals (REGN) had its price target raised by TD Cowen from $880.00 to $960.00. They now have a "buy" rating on the stock.
Ratings data for REGN provided by MarketBeat
Stopped prediction by TD_Cowen for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€981.40
23.07.24
23.07.24
€1,105.1
23.07.25
23.07.25
-50.36%
24.07.25
24.07.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€850.80
24.04.24
24.04.24
€962.84
24.04.25
24.04.25
-37.64%
25.04.25
25.04.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€781.00
06.12.23
06.12.23
€927.70
06.12.24
06.12.24
-4.94%
07.12.24
07.12.24